166 related articles for article (PubMed ID: 16626893)
1. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.
Wallin AR; Svanvik J; Adell G; Sun XF
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):452-8. PubMed ID: 16626893
[TBL] [Abstract][Full Text] [Related]
2. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.
Loftås P; Onnesjö S; Widegren E; Adell G; Kayed H; Kleeff J; Zentgraf H; Sun XF
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):137-42. PubMed ID: 19289258
[TBL] [Abstract][Full Text] [Related]
3. Expression of MAC30 in rectal cancers with or without preoperative radiotherapy.
Zhang ZY; Zhao ZR; Adell G; Jarlsfelt I; Cui YX; Kayed H; Kleeff J; Wang MW; Sun XF
Oncology; 2006; 71(3-4):259-65. PubMed ID: 17657172
[TBL] [Abstract][Full Text] [Related]
4. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
5. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy.
Knutsen A; Adell G; Sun XF
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):149-55. PubMed ID: 15337550
[TBL] [Abstract][Full Text] [Related]
6. Significance of Cox-2 expression in rectal cancers with or without preoperative radiotherapy.
Pachkoria K; Zhang H; Adell G; Jarlsfelt I; Sun XF
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):739-44. PubMed ID: 16199309
[TBL] [Abstract][Full Text] [Related]
7. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
8. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
[TBL] [Abstract][Full Text] [Related]
9. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
[TBL] [Abstract][Full Text] [Related]
10. Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.
Yang L; Zhang H; Zhou ZG; Yan H; Adell G; Sun XF
Clin Cancer Res; 2011 Jun; 17(11):3760-70. PubMed ID: 21531809
[TBL] [Abstract][Full Text] [Related]
11. The expression of the phosphatase regenerating liver 3 gene is associated with outcome in patients with colorectal cancer.
Tamagawa H; Oshima T; Yoshihara K; Watanabe T; Numata M; Yamamoto N; Tuschida K; Shiozawa M; Morinaga S; Akaike M; Masuda M; lmada T
Hepatogastroenterology; 2012 Oct; 59(119):2122-6. PubMed ID: 22440248
[TBL] [Abstract][Full Text] [Related]
12. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of PRL-3 overexpression in early stages of colonic cancer.
Xing X; Peng L; Qu L; Ren T; Dong B; Su X; Shou C
Histopathology; 2009 Feb; 54(3):309-18. PubMed ID: 19236507
[TBL] [Abstract][Full Text] [Related]
14. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
Klenova A; Georgiev R; Kurtev P; Kurteva G
J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
[TBL] [Abstract][Full Text] [Related]
15. Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.
Eriksen MT; Wibe A; Haffner J; Wiig JN;
Dis Colon Rectum; 2007 Feb; 50(2):156-67. PubMed ID: 17180256
[TBL] [Abstract][Full Text] [Related]
16. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
Klenova A; Parvanova V; Georgiev R; Gesheva N
J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
[TBL] [Abstract][Full Text] [Related]
17. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers.
Moparthi SB; Arbman G; Wallin A; Kayed H; Kleeff J; Zentgraf H; Sun XF
Int J Oncol; 2007 Jan; 30(1):91-5. PubMed ID: 17143516
[TBL] [Abstract][Full Text] [Related]
18. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
[TBL] [Abstract][Full Text] [Related]
19. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E;
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570
[TBL] [Abstract][Full Text] [Related]
20. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]